DIGITAL EDITION

ARCHIVES

Category: Topics

Attention Deficit Hyperactivity Disorder Subtypes and Symptom Response in Adults Treated With Lisdexamfetamine Dimesylate

by Greg Mattingly, MD; Richard Weisler, MD; Bryan Dirks, MD; Thomas Babcock, DO; Ben Adeyi, MS; Brian Scheckner, PharmD; and Robert Lasser, MD Dr. Mattingly is from Washington University School

REMS, Patient Safety, and Professional Liability Risks

by Kathryn E. Heagerty, BSN, JD Ms. Heagerty is a Risk Manager for PRMS, Inc. Innov Clin Neurosci. 2012;9(3):27–29